Tectonic Therapeutic | AVRO - Interest Income


Tectonic Therapeutic reported $1.74M in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
Celltrion KRW 779M 157.66M Mar/2026
Dianthus Therapeutics USD 6.26M 2.61M Mar/2026
Gilead Sciences USD 95M 0 Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
MacroGenics USD 1.55M 26K Mar/2026
Medical Developments International AUD 174K 31K Dec/2024
Pfizer USD -0.04 115M Jun/2026
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 10.56M 9.44M Mar/2026
Sanofi EUR 77M 17M Jun/2026
Sarepta Therapeutics USD 7M 1.74M Mar/2026
Sartorius EUR 14.8M 5.3M Jun/2026
Takeda JPY 24.61B 213.76B Jun/2026
Tilray USD 12.83M 20.19M May/2024
Zealand Pharma A/S 74M 28.41M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026